BIO MEDICA LABORATORIES L (BMLL-SM) Share Price Rises 8.16% as Micro Cap Stock Enters Top Gainers

BIO MEDICA LABORATORIES L at Rs 159, up 8.16% today, with market capitalisation of Rs 184.85 crore, has emerged among the session's notable micro cap gainers.

BIO MEDICA LABORATORIES L Share Price was at Rs 159 on 18 August 2026, up Rs 12 or 8.16% from the previous close of Rs 147, taking the company’s market capitalisation to Rs 184.85 crore. For traders scanning Stock Market Today and Top Gainers Today lists, that made the counter one of the more visible micro cap names in the Healthcare space during today’s session.

The verified data confirms a clear same-day price rise in BIO MEDICA LABORATORIES L Share Price, with the stock opening at Rs 149.15, touching a day high of Rs 163.05, and not falling below its opening print of Rs 149.15 through the session low. That price path matters because it shows buying interest appeared early and held through a meaningful intraday range rather than being driven only by a brief spike. On the supplied workflow classification, the stock was captured under a price rise threshold event and placed in the Micro Cap market-cap category.

Why is it trending in BIO MEDICA LABORATORIES L Stock News and BIO MEDICA LABORATORIES L News Today searches? The data establishes the move in price, volume and turnover, but it does not establish a company-specific catalyst behind today’s rally. What investors can monitor next is whether the stock sustains attention through continued turnover, how its valuation compares with the Pharmaceuticals & Drugs benchmark, and whether profitability ratios such as ROE of 13.67 and ROCE of 10.17 justify the current interest. Univest notes that the stock’s move is notable not because it hit a record level, but because the day’s gain itself was large enough to place it among today’s market movers.

BIO MEDICA LABORATORIES L (BMLL-SM) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 159
Previous Close	Rs 147
Today's Change	+Rs 12 (+8.16%)
Day Open	Rs 149.15
Day High	Rs 163.05
Day Low	Rs 149.15
Current Volume (NSE)	88,000
NSE Traded Volume	88,000
Combined NSE + BSE Volume	88,000
Turnover	Rs 1.4 crore
Market Capitalisation	Rs 184.85 crore
Market Cap Category	Micro Cap

BIO MEDICA LABORATORIES L (BMLL-SM) traded at Rs 159. versus the previous close of Rs 147, a rise of 8.16%. The stock opened at Rs 149.15, reached Rs 163.05, touched Rs 149.15. Reported volume was 88,000.

BIO MEDICA LABORATORIES L (BMLL-SM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 184.85 crore
P/E Ratio	15.84x
P/B Ratio	10.2x
ROE	13.67%
ROCE	10.17%
EPS	Rs 9.28
Dividend Yield	0%

BIO MEDICA LABORATORIES L was valued at a P/E ratio of 15.84x, a P/B ratio of 10.2x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 13.67% and ROCE of 10.17%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 9.28, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

BIO MEDICA LABORATORIES L Fundamental Analysis shows a micro cap company that is profitable on the supplied ratios, but whose valuation needs to be read carefully against industry benchmarks. At a market capitalisation of Rs 184.85 crore and a P/E ratio of 15.84, the stock is not being valued like the higher-multiple names often seen in the broader pharmaceuticals space. That can matter in BIO MEDICA LABORATORIES L Stock Analysis because today’s share price gain is arriving from a base that is below the industry’s median and average earnings multiple.

The P/B ratio stands at 10.2, which is a very different signal from the P/E. Price to book measures how richly the market values the company relative to its accounting net worth, and on this metric the stock is carrying a much higher multiple than the industry median of 1.82 and average of 2.49. That means BIO MEDICA LABORATORIES L Share Price is inexpensive relative to many peers on earnings, but not on book value. Investors following BIO MEDICA LABORATORIES L Financial Results and BIO MEDICA LABORATORIES L Earnings themes should therefore avoid relying on any single ratio in isolation.

Profitability data adds further nuance. ROE is 13.67, which indicates the company generated a 13.67% return on shareholder equity, while ROCE is 10.17, a measure of returns generated on capital employed. These are positive readings, showing the business is producing returns rather than losses on the supplied snapshot. EPS is Rs 9.28, which means earnings attributable to each share are meaningful relative to the current price of Rs 159. Dividend yield is 0, so the present data does not show a cash payout yield supporting the stock at this stage.

Overall, the fundamental picture behind BIO MEDICA LABORATORIES L Share Price Today is mixed but relevant. The stock trades on a lower-than-industry P/E, has positive ROE and ROCE, and carries a measurable earnings base through EPS of Rs 9.28. At the same time, the elevated P/B ratio suggests the market is assigning a premium to the company’s book value relative to much of its industry set. For Univest readers, that makes the stock worth tracking as a valuation contrast rather than treating today’s move as a standalone price event. The next lens is sector positioning, because relative metrics are especially important in pharmaceuticals.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	15.84x
Benchmark Median P/E	26.24x
Benchmark Average P/E	39.98x
Benchmark P/E Range	2.96x to 359.13x
Company P/B Ratio	10.2x
Benchmark Median P/B	1.82x
Company ROE	13.67%
Benchmark Median ROE	10.49%
Company ROCE	10.17%
Benchmark Median ROCE	12.97%
Company Market Capitalisation	Rs 184.85 crore
Benchmark Median Market Cap	Rs 142.37 crore

BIO MEDICA LABORATORIES L (BMLL-SM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

BIO MEDICA LABORATORIES L (BMLL-SM) has a P/E ratio of 15.84x, which is below the benchmark median of 26.24x, a difference of -39.63%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

BIO MEDICA LABORATORIES L (BMLL-SM) has a ROE of 13.67%, which is above the benchmark median of 10.49%, a difference of +30.31%. BIO MEDICA LABORATORIES L (BMLL-SM) has a ROCE of 10.17%, which is below the benchmark median of 12.97%, a difference of -21.59%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

The sector backdrop shows BIO MEDICA LABORATORIES L operating in Healthcare, specifically the Pharmaceuticals & Drugs industry, where the benchmark set covers 136 companies in the same industry. That broader frame is important because BIO MEDICA LABORATORIES L Share Price Today is moving within a segment where valuation and profitability ranges are wide, making relative comparison more useful than headline numbers alone.

On earnings valuation, the company’s P/E of 15.84 sits below the same-industry median of 26.24 and well below the average of 39.98. The benchmark range itself runs from 2.96 to 359.13 across 105 companies with available P/E data, so the industry contains both deeply discounted and very richly valued names. In that context, BIO MEDICA LABORATORIES L Share Price does not screen as aggressively priced on earnings. However, its P/B of 10.2 is far above the industry median of 1.82 and average of 2.49, and still below the range high of 16.76. That makes the valuation conversation more complex than a simple low-P/E story.

Profitability against the industry benchmark is also mixed. The company’s ROE of 13.67 is above the median ROE of 10.49 and above the average of 8.1 across 135 companies, suggesting shareholder returns are stronger than many names in the group. By contrast, ROCE of 10.17 sits below the median of 12.97 and below the average of 15.53, which implies capital efficiency is not yet as strong as the broader industry set. Market capitalisation of Rs 184.85 crore is above the industry median market cap of Rs 142.37 crore but below the average of Rs 492.43 crore, reflecting the skew created by larger companies in the sample. Univest views this as a useful reminder that BIO MEDICA LABORATORIES L Market Cap places it in the smaller end of the listed pharma landscape even as today’s move has pushed it into current Market News screens.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,985.15	170.32	0.42	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,827.67	65.02	10.29	18.65	22.17
Hikal Ltd.	HIKAL	2,686.72	0	2.2	15.22	16.15
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,645.37	47.53	1.82	-0.78	8.31
Fredun Pharmaceuticals Ltd.	FREDUN	2,559.68	54.85	8.19	11.42	13.15

BIO MEDICA LABORATORIES L (BMLL-SM) has a P/E ratio of 15.84x compared with the displayed peer median of 54.85x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 13.67% compares with a peer median of 11.42% across the companies shown in the table. ROCE stood at 10.17% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. BIO MEDICA LABORATORIES L (BMLL-SM) has a market capitalisation of Rs 184.85 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Peer comparison places BIO MEDICA LABORATORIES L against a supplied listed set that includes Dishman Carbogen Amcis, Beta Drugs, Hikal, Ind-Swift Laboratories, Fredun Pharmaceuticals, Solara Active Pharma Sciences, Sai Parenteral’s, Panacea Biotec, Venus Remedies and NGL Fine-Chem. On size, BIO MEDICA LABORATORIES L remains far smaller than all of these names, with a market cap of Rs 184.85 crore against peer market values ranging from Rs 2,139.2 crore to Rs 2,985.15 crore.

On P/E, the company’s 15.84 is below Dishman Carbogen Amcis at 170.32, Beta Drugs at 65.02, Ind-Swift Laboratories at 47.53, Fredun Pharmaceuticals at 54.85, Sai Parenteral’s at 170.53, Venus Remedies at 20.48 and NGL Fine-Chem at 31.64. That makes BIO MEDICA LABORATORIES L Share Price look less expensive than many named peers on earnings. Yet P/B tells a different story. Its P/B of 10.2 is near Beta Drugs at 10.29 and above Fredun Pharmaceuticals at 8.19, NGL Fine-Chem at 5.21, Venus Remedies at 3.47, Sai Parenteral’s at 3.12, and several others that sit far lower.

Return ratios again show a middle-ground profile. ROE of 13.67 is better than Dishman Carbogen Amcis at -2.89, Ind-Swift Laboratories at -0.78, Fredun Pharmaceuticals at 11.42, Panacea Biotec at 0 and Venus Remedies at 9.85. However, it trails Beta Drugs at 18.65, Hikal at 15.22, Solara at 17.23 and NGL Fine-Chem at 27.9. ROCE of 10.17 is stronger than Dishman Carbogen Amcis at -0.26, Panacea Biotec at 5.36 and Venus Remedies at 7.89, but below Beta Drugs at 22.17, Hikal at 16.15, Fredun Pharmaceuticals at 13.15, Sai Parenteral’s at 12.97 and NGL Fine-Chem at 33.91. For Univest, the peer set suggests BIO MEDICA LABORATORIES L Share Price Rise is happening in a stock that is relatively modestly valued on P/E, premium valued on P/B, and positioned around the middle of the pack on profitability.

Why Investors Are Watching BIO MEDICA LABORATORIES L

BIO MEDICA LABORATORIES L Share Price is being watched because today’s move combines visible price action with a valuation profile that does not tell a one-dimensional story. The stock has entered the conversation among Top Gainers Today and Stocks Rising Today, but the bigger question is how long that attention lasts and what the numbers say underneath the move.

• Verified price action: the stock rose 8.16% to Rs 159 from Rs 147, after opening at Rs 149.15 and touching Rs 163.05.
• Trading activity: 88,000 shares changed hands on the NSE, with turnover of Rs 1.4 crore.
• Valuation context: P/E at 15.84 is below the same-industry median of 26.24, while P/B at 10.2 is above the industry median of 1.82.
• Profitability profile: ROE is 13.67 and ROCE is 10.17, indicating positive returns but mixed relative standing versus the benchmark.
• Sector positioning: the company operates in Healthcare, within Pharmaceuticals & Drugs, across a benchmark universe of 136 companies.

What should investors monitor next? Watch whether BIO MEDICA LABORATORIES L Share Price Live remains active after today’s rise, whether turnover stays supportive, and whether future company updates alter the balance between lower earnings valuation and high book-value valuation. Univest also highlights peer-relative profitability as an area to follow, because stronger ROE than the industry median is a constructive marker, while lower ROCE than the median keeps the analysis balanced.

About BIO MEDICA LABORATORIES L

BIO MEDICA LABORATORIES L is a listed Indian company traded under the symbol BMLL-SM and classified in the Healthcare sector, specifically within the Pharmaceuticals & Drugs industry. Based on the supplied market data, it is currently a micro cap company with a market capitalisation of Rs 184.85 crore, which places it above the industry median size of Rs 142.37 crore but far below many established listed pharma peers.

The available data does not extend to product lines, business segments or revenue mix, so the cleanest verified description is its market classification and relative position inside the listed pharma universe. That still matters for BIO MEDICA LABORATORIES L Company News and BIO MEDICA LABORATORIES L Latest News searches, because sector membership shapes how investors compare valuation and returns. In this case, the relevant comparison pool is the Pharmaceuticals & Drugs benchmark covering 136 companies.

Within that universe, BIO MEDICA LABORATORIES L stands out less for scale and more for contrast in its metrics. The stock carries a P/E below industry norms, a P/B above them, an ROE above the industry median, and an ROCE below the industry median. Those cross-currents help explain why BIO MEDICA LABORATORIES L Share News can attract attention after a strong one-day move even without a verified company-specific catalyst in the supplied data.

Track BIO MEDICA LABORATORIES L Share Price on Univest

Use BIO MEDICA LABORATORIES L (BMLL-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors tracking BIO MEDICA LABORATORIES L Share Price can use Univest to follow live share price moves, market-cap changes, valuation ratios, peer comparisons and sector benchmarks in one place. BIO MEDICA LABORATORIES L Share Price Today is only one layer of the story; the broader picture also includes P/E, P/B, ROE, ROCE, EPS, dividend yield and 52-week reference levels when available through platform data.

Univest also helps users monitor BIO MEDICA LABORATORIES L Stock News, price action, market insights and comparative metrics across the Healthcare and Pharmaceuticals & Drugs space. For investors reviewing Market Movers and Stock Updates, the key advantage is seeing today’s gain alongside the financial context rather than as an isolated trading print.

Frequently Asked Questions

Why did BIO MEDICA LABORATORIES L Share Price rise today?

Ans. BIO MEDICA LABORATORIES L Share Price rose because the stock gained Rs 12, or 8.16%, from Rs 147 to Rs 159 in today’s session. The supplied data confirms the price event and trading activity, but does not establish a company-specific.

What is BIO MEDICA LABORATORIES L Share Price Today?

Ans. BIO MEDICA LABORATORIES L Share Price Today was Rs 159 at the time of the supplied snapshot. That compares with a previous close of Rs 147, meaning the stock was higher by Rs 12 and had posted an 8.16% day.

What were the day high, day low and opening price of the stock?

Ans. The stock opened at Rs 149.15, touched a day high of Rs 163.05 and recorded a day low of Rs 149.15. This shows the session began at the low and the stock traded above the previous close throughout.

How much volume was traded in BIO MEDICA LABORATORIES L today?

Ans. BIO MEDICA LABORATORIES L recorded total traded volume of 88,000 shares on the NSE, with turnover of Rs 1.4 crore. For a micro cap stock with market capitalisation of Rs 184.85 crore, that activity made the move notable today.

What is the market capitalisation of BIO MEDICA LABORATORIES L?

Ans. The company’s market capitalisation is Rs 184.85 crore based on the supplied data. That places it in the Micro Cap category and above the industry median market cap of Rs 142.37 crore within the same benchmark set.

Is BIO MEDICA LABORATORIES L expensive or cheap on valuation?

Ans. On P/E, the stock looks lower priced than its industry benchmark, with a ratio of 15.84 against a median of 26.24. On P/B, however, it looks richer, at 10.2 versus the industry median of 1.82.

What do the company’s profitability ratios show?

Ans. The supplied ratios show ROE of 13.67 and ROCE of 10.17. ROE is above the industry median of 10.49, while ROCE is below the industry median of 12.97, giving a mixed but still profitable operating picture.

What is the EPS and dividend yield of BIO MEDICA LABORATORIES L?

Ans. BIO MEDICA LABORATORIES L has EPS of Rs 9.28 and a dividend yield of 0 in the supplied dataset. EPS reflects earnings attributable to each share, while the yield figure indicates no current historical payout yield is shown here.

How does BIO MEDICA LABORATORIES L compare with listed pharma peers?

Ans. The company is much smaller than supplied peers such as Beta Drugs, Hikal and Venus Remedies by market cap. Its P/E of 15.84 is below many peers, while its P/B of 10.2 is among the higher ratios in the set.

What should investors monitor after this share price rise?

Ans. Investors can monitor whether turnover and traded volume remain active after today’s 8.16% move, and whether future company updates change the balance between lower P/E valuation, high P/B valuation, and mixed profitability relative to industry benchmarks.